|
 |
|
July 2026
|
|
|
Updates from Leadership
|
|
Hiring: Chief Medical Research Officers
NHLBI is seeking candidates for the positions of Chief Medical Research Officers (CMROs) within the Division of Blood Diseases and Resources, Division of Cardiovascular Sciences, and Division of Lung Diseases. We invite the community to share the job announcement across your networks and encourage candidates of interest to apply.
Applications Due: July 27, 2026
|
|
Division of Cardiovascular Science (DCVS) Leadership Updates
Dr. Renee Wong will serve as the Acting Associate Director for DCVS overseeing the Adult and Pediatric Cardiac Research Program. In her capacity as DCVS Acting Associate Director, Dr. Wong will provide leadership for basic, pre-clinical and early translational studies, and clinical trials research on heart development and function from birth through adulthood.
|
|
|
Dr. Lisa Schwartz Longacre will serve as the Acting Branch Chief for Heart Failure and Arrhythmias. In this role, Dr. Schwartz Longacre will oversee an integrated basic and clinical research program in heart failure, arrhythmias, myocardial protection, cardiotoxicity, and resuscitation science.
|
|
|
Notices of Funding Opportunities, Policy Changes, Requests for Information
|
|
NHLBI Notice of Funding Opportunities
Notice Number
|
Title
|
Closing Date
|
|
PA-27-100
|
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
|
Apr 6, 2027
|
|
PA-27-102
|
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
|
Apr 6, 2027
|
|
PAR-27-098
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
|
Apr 6, 2029
|
|
PA-27-101
|
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
|
Apr 6, 2029
|
|
|
Request for Information
NIH Seeks Input on Effective Approaches for Measuring and Rewarding Scientific Impact
NIH is seeking feedback from the public that reflects the collaborative, rigorous, and mission-driven nature of modern biomedical science.
NIH is particularly interested in comments that include specific examples of measurable indicators, implementation approaches, potential benefits or unintended consequences, and considerations for feasibility across career stages, disciplines, and institution types.
Comments due August 19, 2026 and must be submitted through the online comment portal.
|
|
Fellowship Opportunities
TOPMed Fellowship Funding Opportunity
The TOPMed Fellowship aims to provide training to early-career investigators, leveraging the TOPMed datasets, and the NHLBI BioData Catalyst (BDC) computing environment to conduct impactful precision medicine research.
Key Reminders:
-
Applications Due: July 22, 2026
-
Include: BDC cost estimates in your budget
-
Engage: BDC early for support with feasibility, workflows, and cost planning
-
Questions: topmed-admin@westat.com
Please note: TOPMed credentials are required to apply.
|
|
Concept to Clinic: Commercializing Innovation (C3i) Program
Medical device innovators with active NHLBI grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering C3i program! The 24-week C3i program provides participants with specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic).
Applications Due: July 31, 2026
| | |
